Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

N-acetyltransferase polymorphisms and colorectal cancer: a HuGE review.

Brockton N, Little J, Sharp L, Cotton SC.

Am J Epidemiol. 2000 May 1;151(9):846-61. Review.

PMID:
10791558
2.

Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms.

Hein DW, Doll MA, Fretland AJ, Leff MA, Webb SJ, Xiao GH, Devanaboyina US, Nangju NA, Feng Y.

Cancer Epidemiol Biomarkers Prev. 2000 Jan;9(1):29-42. Review.

3.

Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.

Okkels H, Sigsgaard T, Wolf H, Autrup H.

Cancer Epidemiol Biomarkers Prev. 1997 Apr;6(4):225-31.

5.

Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases.

Hein DW, Doll MA, Rustan TD, Gray K, Feng Y, Ferguson RJ, Grant DM.

Carcinogenesis. 1993 Aug;14(8):1633-8.

PMID:
8353847
6.

Inherited polymorphism in the N-acetyltransferase 1 (NAT1) and 2 (NAT2) genes and susceptibility to gastric and colorectal adenocarcinoma.

Katoh T, Boissy R, Nagata N, Kitagawa K, Kuroda Y, Itoh H, Kawamoto T, Bell DA.

Int J Cancer. 2000 Jan 1;85(1):46-9.

7.

Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption.

Lilla C, Verla-Tebit E, Risch A, Jäger B, Hoffmeister M, Brenner H, Chang-Claude J.

Cancer Epidemiol Biomarkers Prev. 2006 Jan;15(1):99-107.

8.

The role of N-acetylation polymorphisms in smoking-associated bladder cancer: evidence of a gene-gene-exposure three-way interaction.

Taylor JA, Umbach DM, Stephens E, Castranio T, Paulson D, Robertson C, Mohler JL, Bell DA.

Cancer Res. 1998 Aug 15;58(16):3603-10.

9.
10.

N-acetyl transferase 1: two polymorphisms in coding sequence identified in colorectal cancer patients.

Hubbard AL, Moyes C, Wyllie AH, Smith CA, Harrison DJ.

Br J Cancer. 1998 Mar;77(6):913-6.

11.

Human acetylator genotype: relationship to colorectal cancer incidence and arylamine N-acetyltransferase expression in colon cytosol.

Rodriguez JW, Kirlin WG, Ferguson RJ, Doll MA, Gray K, Rustan TD, Lee ME, Kemp K, Urso P, Hein DW.

Arch Toxicol. 1993;67(7):445-52.

PMID:
7902079
13.

N-acetyltransferase NAT1 and NAT2 genotypes and lung cancer risk.

Bouchardy C, Mitrunen K, Wikman H, Husgafvel-Pursiainen K, Dayer P, Benhamou S, Hirvonen A.

Pharmacogenetics. 1998 Aug;8(4):291-8.

PMID:
9731715
14.

Cigarette smoking, N-acetyltransferase genes and the risk of advanced colorectal adenoma.

Moslehi R, Chatterjee N, Church TR, Chen J, Yeager M, Weissfeld J, Hein DW, Hayes RB.

Pharmacogenomics. 2006 Sep;7(6):819-29.

PMID:
16981843
16.

Polymorphic NATs and cancer predisposition.

Hirvonen A.

IARC Sci Publ. 1999;(148):251-70. Review.

PMID:
10493262
17.

Polymorphisms of glutathione-S-transferase and arylamine N-acetyltransferase enzymes and susceptibility to colorectal cancer.

Kiss I, Németh A, Bogner B, Pajkos G, Orsós Z, Sándor J, Csejtey A, Faluhelyi Z, Rodler I, Ember I.

Anticancer Res. 2004 Nov-Dec;24(6):3965-70.

18.

Effects of N-acetyl transferase 1 and 2 polymorphisms on bladder cancer risk in Caucasians.

Gu J, Liang D, Wang Y, Lu C, Wu X.

Mutat Res. 2005 Mar 7;581(1-2):97-104. Epub 2004 Dec 16.

PMID:
15725609
19.
20.

Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer.

Bell DA, Stephens EA, Castranio T, Umbach DM, Watson M, Deakin M, Elder J, Hendrickse C, Duncan H, Strange RC.

Cancer Res. 1995 Aug 15;55(16):3537-42.

Supplemental Content

Support Center